Add to ORKGdBackground: Recent registries have shown that recommended drugs for the treatment of chronic heart failure (CHF) are under-prescribed in In western countries, chronic heart failure (CHF) is a growing health problem, which is in part related to increased survival in patients with CHF due to left ventricular systolic dysfunction, following treatment with angiotensin converting enzyme inhibitors (ACE-I), angiotensin-2 receptor blockers (ARB), beta-blockers and aldosterone antagonists [1–6]
Heart failure (HF) and coronary insufficiency are common amongst surgical and critical care patients...
The clinical diagnosis of heart failure is independent of aetiology. Treatment strategies are aimed ...
Background: Heart failure (HF) is a global challenge, with lower- and middle-income countries (LMICs...
Evidence-based medicine requires that clinical benefits should be evaluated by 'hard ' end...
Chronic heart failure (CHF) today is a heart condition with the least favourable prognosis. Over the...
International audienceHeart failure is the most common cardiovascular reason for hospital admission ...
Abstract Background: Our goal is to review the current treatment recommendations for chronic heart ...
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Chronic heart failure (CHF) is a large medical problem, but in recent years significant progress has...
Treatment of heart failure has undergone major changes in the last two decades. European and US guid...
Ž.Chronic heart failure CHF is a major public health problem with high attendant morbidity and morta...
approach to â blockers in heart failure Congestive heart failure (CHF) is a growing public health pr...
Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in tran...
Aims: Internationally, research indicates that pharmacotherapy for chronic heart failure (CHF) is su...
This editorial refers to $Decreasing one-year mortality and hospitalization rates for heart failure ...
Heart failure (HF) and coronary insufficiency are common amongst surgical and critical care patients...
The clinical diagnosis of heart failure is independent of aetiology. Treatment strategies are aimed ...
Background: Heart failure (HF) is a global challenge, with lower- and middle-income countries (LMICs...
Evidence-based medicine requires that clinical benefits should be evaluated by 'hard ' end...
Chronic heart failure (CHF) today is a heart condition with the least favourable prognosis. Over the...
International audienceHeart failure is the most common cardiovascular reason for hospital admission ...
Abstract Background: Our goal is to review the current treatment recommendations for chronic heart ...
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Chronic heart failure (CHF) is a large medical problem, but in recent years significant progress has...
Treatment of heart failure has undergone major changes in the last two decades. European and US guid...
Ž.Chronic heart failure CHF is a major public health problem with high attendant morbidity and morta...
approach to â blockers in heart failure Congestive heart failure (CHF) is a growing public health pr...
Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in tran...
Aims: Internationally, research indicates that pharmacotherapy for chronic heart failure (CHF) is su...
This editorial refers to $Decreasing one-year mortality and hospitalization rates for heart failure ...
Heart failure (HF) and coronary insufficiency are common amongst surgical and critical care patients...
The clinical diagnosis of heart failure is independent of aetiology. Treatment strategies are aimed ...
Background: Heart failure (HF) is a global challenge, with lower- and middle-income countries (LMICs...